Patrícia Helena Medeiros Cézar de Oliveira Rodrigues, M. March, Regina Kátia Cerqueira Ribeiro, C. Sant´Anna
{"title":"7 ~ 14岁儿童和青少年哮喘患者最大呼吸压的评价","authors":"Patrícia Helena Medeiros Cézar de Oliveira Rodrigues, M. March, Regina Kátia Cerqueira Ribeiro, C. Sant´Anna","doi":"10.4172/2161-105X.1000404","DOIUrl":null,"url":null,"abstract":"Objectives: To evaluate the respiratory muscle strength among children (<10 years old) and adolescents with asthma. \nMethods: This is a cross-sectional, retrospective study, among children and adolescents (7 years to 14 years of age) with asthma. Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) [in cmH2O] were measured through digital manometer. The variables evaluated were: gender, age, BMI (body mass index), severity of asthma, use of inhaled corticosteroid (IC). \nResults: A total of 48 individuals were studied. MIP values were according: a) normal weight=69.5 ± 22.6; overweight=81.6 ± 25.4 (p<0.088); b) use of inhaled corticosteroid=70.5 ± 23.0; no use=25.1 ± 86.3 (p<0.045). MEP values according: a) ages 7-9 years=78.8 ± 19.4; 10-14 years=68.1 ± 22.7 (p<0.097); b) normal weight=66.1 ± 18.9; overweight=80.3 ± 23.3 (p<0.024); c) use of inhaled corticosteroid=68.3 ± 18.3; no use=83.1 ± 27.5 (p<0.036); d) with bronchiectasis=61.8 ± 19.2; without bronchiectasis=83.1 ± 27.5 (p<0.069). \nConclusions: Patients who used inhaled corticosteroid had MIP and MEP lower than the others; patients with normal BMI tended to have lower MEP than the overweight group and lower MIP in the group of normal weight. There was a tendency of adolescents to present lower MEP than children.","PeriodicalId":90449,"journal":{"name":"Austin journal of pulmonary and respiratory medicine","volume":"21 2-4","pages":"1-4"},"PeriodicalIF":0.0000,"publicationDate":"2017-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of the Maximal Respiratory Pressure in Children and Adolescentswith Asthma between 7 and 14 Years Old\",\"authors\":\"Patrícia Helena Medeiros Cézar de Oliveira Rodrigues, M. March, Regina Kátia Cerqueira Ribeiro, C. Sant´Anna\",\"doi\":\"10.4172/2161-105X.1000404\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objectives: To evaluate the respiratory muscle strength among children (<10 years old) and adolescents with asthma. \\nMethods: This is a cross-sectional, retrospective study, among children and adolescents (7 years to 14 years of age) with asthma. Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) [in cmH2O] were measured through digital manometer. The variables evaluated were: gender, age, BMI (body mass index), severity of asthma, use of inhaled corticosteroid (IC). \\nResults: A total of 48 individuals were studied. MIP values were according: a) normal weight=69.5 ± 22.6; overweight=81.6 ± 25.4 (p<0.088); b) use of inhaled corticosteroid=70.5 ± 23.0; no use=25.1 ± 86.3 (p<0.045). MEP values according: a) ages 7-9 years=78.8 ± 19.4; 10-14 years=68.1 ± 22.7 (p<0.097); b) normal weight=66.1 ± 18.9; overweight=80.3 ± 23.3 (p<0.024); c) use of inhaled corticosteroid=68.3 ± 18.3; no use=83.1 ± 27.5 (p<0.036); d) with bronchiectasis=61.8 ± 19.2; without bronchiectasis=83.1 ± 27.5 (p<0.069). \\nConclusions: Patients who used inhaled corticosteroid had MIP and MEP lower than the others; patients with normal BMI tended to have lower MEP than the overweight group and lower MIP in the group of normal weight. There was a tendency of adolescents to present lower MEP than children.\",\"PeriodicalId\":90449,\"journal\":{\"name\":\"Austin journal of pulmonary and respiratory medicine\",\"volume\":\"21 2-4\",\"pages\":\"1-4\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-05-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Austin journal of pulmonary and respiratory medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2161-105X.1000404\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Austin journal of pulmonary and respiratory medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2161-105X.1000404","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Evaluation of the Maximal Respiratory Pressure in Children and Adolescentswith Asthma between 7 and 14 Years Old
Objectives: To evaluate the respiratory muscle strength among children (<10 years old) and adolescents with asthma.
Methods: This is a cross-sectional, retrospective study, among children and adolescents (7 years to 14 years of age) with asthma. Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) [in cmH2O] were measured through digital manometer. The variables evaluated were: gender, age, BMI (body mass index), severity of asthma, use of inhaled corticosteroid (IC).
Results: A total of 48 individuals were studied. MIP values were according: a) normal weight=69.5 ± 22.6; overweight=81.6 ± 25.4 (p<0.088); b) use of inhaled corticosteroid=70.5 ± 23.0; no use=25.1 ± 86.3 (p<0.045). MEP values according: a) ages 7-9 years=78.8 ± 19.4; 10-14 years=68.1 ± 22.7 (p<0.097); b) normal weight=66.1 ± 18.9; overweight=80.3 ± 23.3 (p<0.024); c) use of inhaled corticosteroid=68.3 ± 18.3; no use=83.1 ± 27.5 (p<0.036); d) with bronchiectasis=61.8 ± 19.2; without bronchiectasis=83.1 ± 27.5 (p<0.069).
Conclusions: Patients who used inhaled corticosteroid had MIP and MEP lower than the others; patients with normal BMI tended to have lower MEP than the overweight group and lower MIP in the group of normal weight. There was a tendency of adolescents to present lower MEP than children.